Clinical Trial Update: A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP [Phase 2]

View source ↗

Summary

Phase 2 randomized open-label study comparing oseltamivir plus high-dose dexamethasone (HD-DEX) versus HD-DEX alone for thrombocytopenia management has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• HD-DEX (dexamethasone)
• OSELTAMIVIR (oseltamivir phosphate)

Snippet

Sponsor: Shandong University | Conditions: Thrombocytopenia | Phase 2 | Status: COMPLETED